NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Indian Equities End Lower on June 3 Amid Crude Oil Price Spike and U.S.-Iran Uncertainty

The Indian equities market experienced a volatile session on June 3, erasing the previous day's gains as the Nifty50 slipped below the 23,200 mark intraday. The market's losses were fueled by a spike in crude oil prices and uncertainty surrounding a potential U.S.-Iran peace deal.

The market started weakly, with the Nifty hitting its day's low of 23,151.50, before recovering some losses in the mid-session, particularly in auto and banking stocks. At close, the Sensex was down 303.67 points or 0.41 percent at 74,346.17, and the Nifty was down 77.95 points or 0.33 percent at 23,405.60.

IndexChangePercentage Change
Sensex-303.67-0.41%
Nifty-77.95-0.33%
Nifty Midcap 100-0.4%
Nifty Smallcap 100-0.1%

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

The losses were led by TCS, Tech Mahindra, HCL Technologies, Infosys, and Wipro, while gains were seen in Apollo Hospitals, Max Healthcare, Tata Motors Passenger Vehicles, SBI, and ICICI Bank. The IT index shed 5.5%, FMCG and realty indices slipped 1% each, and Consumer Durables fell 0.8%. Conversely, the Telecom index rose 2%, PSU Bank index jumped 1.7%, and the healthcare index was up 0.5%.

More than 100 stocks touched their 52-week high on the BSE, including Apar Industries, IFCI, Vodafone Idea, Chennai Petro, HFCL, Federal Bank, Welspun Corp, JK Bank, NMDC, Technologies India, PTC Industries, ACME Solar, and others.

Among individual stocks, John Cockerill India surged 20% to hit a 52-week high after securing an order worth ₹1,250–1,300 crore. Advait Energy Transitions gained 5% after signing a Battery Energy Storage Purchase Agreement (BESPA) with Gujarat Urja Vikas Nigam Ltd (GUVNL). Bliss GVS Pharma also hit a 52-week high after its Palghar manufacturing facility received an Inspection Closure Report from the World Health Organization (WHO), while Concord Biotech rose 2.5% following USFDA approval for Mycophenolate Mofetil for Oral Suspension USP.

NHPC advanced 3.5% as retail bidding opened after its oversubscribed Offer for Sale (OFS). On the other hand, Lenskart Solutions slipped 1.5% after 3.25% equity changed hands in a large block deal.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Market Outlook for June 4

According to Rupak De, Senior Technical Analyst at LKP Securities, the index recovered smartly during the day but failed to reclaim the 20 EMA on the hourly chart, keeping the possibility of another decline alive. A lower-top, lower-bottom formation is visible on the hourly timeframe, indicating a bearish trend in the recent price structure.

Sudeep Shah, Head - Technical and Derivatives Research at SBI Securities, stated that Nifty opened with a gap-down and extended its decline in the first half of the session. However, strong buying interest emerged at lower levels, helping the index recover sharply from the day's lows and recoup most of its intraday losses. Nifty eventually closed at 23,406, down 0.33%.

Going ahead, the immediate resistance for Nifty is placed in the 23,530-23,550 zone. Any sustainable move above this zone could result in Nifty extending its pullback towards 23,700, followed by 23,950 in the short term. On the downside, the immediate support for Nifty is placed in the 23,270-23,250 zone.

Investor Takeaway

Investors should be cautious of the IT sector's decline and potential impact on the overall market.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.